Edgecock, T. R. et al, Agarwalla, S. K., Cervera-Villanueva, A., Donini, A., Ghosh, T., Gomez-Cadenas, J. J., et al. (2013). High intensity neutrino oscillation facilities in Europe. Phys. Rev. Spec. Top.-Accel. Beams, 16(2), 021002–18pp.
Abstract: The EUROnu project has studied three possible options for future, high intensity neutrino oscillation facilities in Europe. The first is a Super Beam, in which the neutrinos come from the decay of pions created by bombarding targets with a 4 MW proton beam from the CERN High Power Superconducting Proton Linac. The far detector for this facility is the 500 kt MEMPHYS water Cherenkov, located in the Frejus tunnel. The second facility is the Neutrino Factory, in which the neutrinos come from the decay of mu(+) and mu(-) beams in a storage ring. The far detector in this case is a 100 kt magnetized iron neutrino detector at a baseline of 2000 km. The third option is a Beta Beam, in which the neutrinos come from the decay of beta emitting isotopes, in particular He-6 and Ne-18, also stored in a ring. The far detector is also the MEMPHYS detector in the Frejus tunnel. EUROnu has undertaken conceptual designs of these facilities and studied the performance of the detectors. Based on this, it has determined the physics reach of each facility, in particular for the measurement of CP violation in the lepton sector, and estimated the cost of construction. These have demonstrated that the best facility to build is the Neutrino Factory. However, if a powerful proton driver is constructed for another purpose or if the MEMPHYS detector is built for astroparticle physics, the Super Beam also becomes very attractive.
|
Roman, F. L., Abler, D., Kanellopoulos, V., Amoros, G., Davies, J., Dosanjh, M., et al. (2013). Hadron therapy information sharing prototype. J. Radiat. Res., 54, 56–60.
Abstract: The European PARTNER project developed a prototypical system for sharing hadron therapy data. This system allows doctors and patients to record and report treatment-related events during and after hadron therapy. It presents doctors and statisticians with an integrated view of adverse events across institutions, using open-source components for data federation, semantics, and analysis. There is a particular emphasis upon semantic consistency, achieved through intelligent, annotated form designs. The system as presented is ready for use in a clinical setting, and amenable to further customization. The essential contribution of the work reported here lies in the novel data integration and reporting methods, as well as the approach to software sustainability achieved through the use of community-supported open-source components.
|
Davesne, D., Pastore, A., & Navarro, J. (2013). Skyrme effective pseudopotential up to the next-to-next-to-leading order. J. Phys. G, 40(9), 095104–8pp.
Abstract: The explicit form of the next-to-next-to-leading order ((NLO)-L-2) of the Skyrme effective pseudopotential compatible with all required symmetries and especially with gauge invariance is presented in a Cartesian basis. It is shown in particular that for such a pseudopotential there is no spin-orbit contribution and that the D-wave term suggested in the original Skyrme formulation does not satisfy the invariance properties. The six new (NLO)-L-2 terms contribute to both the equation of state and the Landau parameters. These contributions to symmetric nuclear matter are given explicitly and discussed.
|
Verdu-Andres, S., Amaldi, U., & Faus-Golfe, A. (2013). CABOTO, a high-gradient linac for hadrontherapy. J. Radiat. Res., 54, 155–161.
Abstract: The field of hadrontherapy has grown rapidly in recent years. At present the therapeutic beam is provided by a cyclotron or a synchrotron, but neither cyclotrons nor synchrotrons present the best performances for hadrontherapy. The new generation of accelerators for hadrontherapy should allow fast active energy modulation and have a high repetition rate, so that moving organs can be appropriately treated in a reasonable time. In addition, a reduction of the dimensions and cost of the accelerators for hadrontherapy would make the acquisition and operation of a hadrontherapy facility more affordable, which would translate into great benefits for the potential hadrontherapy patients. The 'cyclinac', an accelerator concept that combines a cyclotron with a high-frequency linear accelerator (linac), is a fast-cycling machine specifically conceived to allow for fast active energy modulation. The present paper focuses on CABOTO (CArbon BOoster for Therapy in Oncology), a compact, efficient high-frequency linac that can accelerate C6+ ions and H-2 molecules from 150-410 MeV/u in similar to 24 m. The paper presents the latest design of CABOTO and discusses its performances.
|
Blankenburg, G., & Jones Perez, J. (2013). RGE behavior of SUSY with a U(2)(3) symmetry. Eur. Phys. J. C, 73(2), 2289–15pp.
Abstract: The first LHC results seem to disfavor, from the point of view of naturalness, any constrained MSSM realization with universal conditions at the SUSY-breaking scale. A more motivated scenario is given by split-family SUSY, in which the first two generations of squarks are heavy, compatible with a U(2)(3) flavor symmetry. We consider this flavor symmetry to be broken at a very high scale and study the consequences at low energies through its RGE evolution. Initial conditions compatible with a split scenario are found, and the preservation of correlations from minimal U(2)(3) breaking are checked. The various chiral operators in Delta F = 2 processes are analyzed, and we show that, due to LHC gluino bounds, the (LL)(RR) operators cannot always be neglected. Finally, we also study a possible extension of the U(2)(3) model compatible with the lepton sector.
|
